On January 4, 2013, the Board of Directors (the "Board") of Endocyte, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee, elected Lesley Russell, M.B.Ch.B., to the Board, with a term to expire at the Company's 2014 annual meeting of stockholders. The appointment fills a newly created directorship position on the Board. The Company expects that Dr. Russell will be appointed to the Audit Committee. There are no arrangements or understandings between Dr. Russell and any other persons pursuant to which Dr. Russell was appointed a director of the Company.

As a non-employee director, Dr. Russell will participate in the non-employee director compensation arrangements described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 13, 2012.

A copy of the Company's press release announcing the appointment of Dr. Russell to the Board is attached hereto as Exhibit 99.1, and the information set forth therein is incorporated herein by reference.

(d) Exhibits

                 Exhibit No.    Description

                       99.1     Press release dated January 8, 2013


--------------------------------------------------------------------------------
  Top of the Form